Literature DB >> 33466303

Stromal Protein-Mediated Immune Regulation in Digestive Cancers.

Pia Gamradt1, Christelle De La Fouchardière1,2, Ana Hennino1,3.   

Abstract

The stromal tumor microenvironment (TME) consists of immune cells, vascular and neural structures, cancer-associated fibroblasts (CAFs), as well as extracellular matrix (ECM), and favors immune escape mechanisms promoting the initiation and progression of digestive cancers. Numerous ECM proteins released by stromal and tumor cells are crucial in providing physical rigidity to the TME, though they are also key regulators of the immune response against cancer cells by interacting directly with immune cells or engaging with immune regulatory molecules. Here, we discuss current knowledge of stromal proteins in digestive cancers including pancreatic cancer, colorectal cancer, and gastric cancer, focusing on their functions in inhibiting tumor immunity and enabling drug resistance. Moreover, we will discuss the implication of stromal proteins as therapeutic targets to unleash efficient immunotherapy-based treatments.

Entities:  

Keywords:  digestive cancers; extracellular matrix (ECM) proteins; immune regulation; tumor microenvironment (TME)

Year:  2021        PMID: 33466303      PMCID: PMC7795083          DOI: 10.3390/cancers13010146

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  242 in total

1.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

2.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Authors:  Clifford J Whatcott; Haiyong Han; Richard G Posner; Galen Hostetter; Daniel D Von Hoff
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

3.  A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.

Authors:  Andrew H Ko; Noelle LoConte; Margaret A Tempero; Evan J Walker; R Kate Kelley; Stephanie Lewis; Wei-Chou Chang; Emily Kantoff; Michael W Vannier; Daniel V Catenacci; Alan P Venook; Hedy L Kindler
Journal:  Pancreas       Date:  2016-03       Impact factor: 3.327

Review 4.  Introductory review: periostin-gene and protein structure.

Authors:  Akira Kudo
Journal:  Cell Mol Life Sci       Date:  2017-09-07       Impact factor: 9.261

Review 5.  Revisiting the hallmarks of cancer: The role of hyaluronan.

Authors:  Ilaria Caon; Barbara Bartolini; Arianna Parnigoni; Elena Caravà; Paola Moretto; Manuela Viola; Evgenia Karousou; Davide Vigetti; Alberto Passi
Journal:  Semin Cancer Biol       Date:  2019-07-15       Impact factor: 15.707

Review 6.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

7.  The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.

Authors:  Chang-Ni Lin; Chih-Jung Wang; Ying-Jui Chao; Ming-Derg Lai; Yan-Shen Shan
Journal:  BMC Cancer       Date:  2015-03-15       Impact factor: 4.430

Review 8.  Regulating IRFs in IFN Driven Disease.

Authors:  Caroline A Jefferies
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

9.  Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.

Authors:  Ana De Jesus-Acosta; Elizabeth A Sugar; Peter J O'Dwyer; Ramesh K Ramanathan; Daniel D Von Hoff; Zeshaan Rasheed; Lei Zheng; Asma Begum; Robert Anders; Anirban Maitra; Florencia McAllister; N V Rajeshkumar; Shinichi Yabuuchi; Roeland F de Wilde; Bhavina Batukbhai; Ismet Sahin; Daniel A Laheru
Journal:  Br J Cancer       Date:  2019-12-20       Impact factor: 7.640

Review 10.  The complexity of integrins in cancer and new scopes for therapeutic targeting.

Authors:  Hellyeh Hamidi; Mika Pietilä; Johanna Ivaska
Journal:  Br J Cancer       Date:  2016-09-29       Impact factor: 7.640

View more
  5 in total

Review 1.  Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.

Authors:  Peijie Wu; Wei Gao; Miao Su; Edouard C Nice; Wenhui Zhang; Jie Lin; Na Xie
Journal:  Front Cell Dev Biol       Date:  2021-03-01

Review 2.  Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications.

Authors:  Karim Rihawi; Angela Dalia Ricci; Alessandro Rizzo; Stefano Brocchi; Giovanni Marasco; Luigi Vincenzo Pastore; Fabiola Lorena Rojas Llimpe; Rita Golfieri; Matteo Renzulli
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

3.  Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database.

Authors:  Danlei Song; Yongjian Wei; Yuping Hu; Xia Chen; Ya Zheng; Min Liu; Yuping Wang; Yongning Zhou
Journal:  Discov Oncol       Date:  2021-11-01

4.  A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3.

Authors:  Christelle de la Fouchardière; Pia Gamradt; Sylvie Chabaud; Maxime Raddaz; Ellen Blanc; Olivier Msika; Isabelle Treilleux; Sophie Bachy; Anne Cattey-Javouhey; Pierre Guibert; Matthieu Sarabi; Pauline Rochefort; Pamela Funk-Debleds; Clélia Coutzac; Isabelle Ray-Coquard; Patrice Peyrat; Pierre Meeus; Michel Rivoire; Aurélien Dupré; Ana Hennino
Journal:  J Pers Med       Date:  2022-04-12

5.  Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer.

Authors:  Songwei Feng; Yi Xu; Zhu Dai; Han Yin; Ke Zhang; Yang Shen
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.